4//SEC Filing
Puhlmann Markus 4
Accession 0001437749-23-034481
CIK 0000728387other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 6:44 PM ET
Size
5.3 KB
Accession
0001437749-23-034481
Insider Transaction Report
Form 4
Puhlmann Markus
Chief Medical Officer
Transactions
- Award
Stock Options (right to buy)
2023-12-12+1,477,619→ 2,885,688 totalExercise: $0.24Exp: 2033-12-12→ Common Stock (1,477,619 underlying)
Footnotes (1)
- [F1]25% vested as of 12/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 12/12/2024, until fully vested.
Documents
Issuer
Perspective Therapeutics, Inc.
CIK 0000728387
Entity typeother
Related Parties
1- filerCIK 0001965071
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 6:44 PM ET
- Size
- 5.3 KB